Oslo, Norway, 20 June 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of its commercial production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback